rxstat › Shortages › Rivaroxaban

Rivaroxaban shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Rivaroxaban products are in shortage in Canada (5 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 30, 2026.
Products affected
5 / 18
In shortage since
Jun 10, 2025
Est. full return
Nov 30, 2026
Reports on file
48
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
M-RIVAROXABAN
10MG · TABLET · MANTRA PHARMA INC
DIN 02551616 · since Apr 20, 2026, est. end Jul 20, 2026 · Delay in shipping of the drug.
Active shortage
APO-RIVAROXABAN
10MG · TABLET · APOTEX INC
DIN 02470497 · since Apr 28, 2026, est. end Jun 12, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-RIVAROXABAN
10MG · TABLET · TEVA CANADA LIMITED
DIN 02507196 · since Jun 10, 2025, est. end Nov 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-RIVAROXABAN
20MG · TABLET · TEVA CANADA LIMITED
DIN 02507226 · since Mar 25, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-RIVAROXABAN
20MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02483823 · since Nov 25, 2025, est. end Jun 19, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ RIVAROXABAN
20MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02482258 · ended May 19, 2026 · Delay in shipping of the drug.
Resolved
TARO-RIVAROXABAN
2.5MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02526786 · ended May 14, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-RIVAROXABAN
20MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02483823 · ended May 15, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-RIVAROXABAN
20MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02483823 · ended May 15, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ RIVAROXABAN
10MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02482223 · ended Mar 2, 2026 · Delay in shipping of the drug.
Resolved
TARO-RIVAROXABAN
10MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02483807 · ended Nov 19, 2025 · Disruption of the manufacture of the drug.
Resolved
XARELTO
10MG · TABLET · BAYER INC
DIN 02316986 · ended Aug 15, 2025 · Delay in shipping of the drug.

Showing 12 of 48 reports. All reports are on file with Health Canada.

What's happening

Rivaroxaban is currently affected by 5 active shortage reports filed with Health Canada by MANTRA PHARMA INC, APOTEX INC, TEVA CANADA LIMITED, TARO PHARMACEUTICALS INC.

The reported causes are: delay in shipping of the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Rivaroxaban is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AF).

Recent changes

Common questions

When will Rivaroxaban be back in stock in Canada?

The latest manufacturer estimate is Nov 30, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Rivaroxaban in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antithrombotic agents)

Widespread shortageNadroparin7 of 8 reported products affectedWidespread shortageTicagrelor2 of 4 reported products affected · est. return Jul 31, 2026Partial shortageBivalirudin1 of 3 reported products affected · est. return Jun 30, 2026Partial shortageClopidogrel4 of 18 reported products affected · est. return Nov 10, 2026Partial shortageDabigatran Etexilate2 of 6 reported products affected · est. return Jun 12, 2026Partial shortageEdoxaban1 of 6 reported products affected · est. return Jul 10, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.